In Brief this Week: Complete Genomics; Illumina; Danaher | GenomeWeb

NEW YORK (GenomeWeb News) – Complete Genomics disclosed in a filing with the US Securities and Exchange Commission this week that another lawsuit has been field against the firm by a "purported stockholder" alleging a breach in fiduciary duties in connection with the firm's proposed $117.6 million merger with BGI. It is the latest in a handful of suits filed against Complete Genomics, its board of directors, and executives seeking to block the deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.